Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tejnaksh HealthcareBOM:539428 -1.72%72 EBITDA Margin % is 27.92% as of Mar. 2026, which is 17% below its 10-year median of 33.79. GuruFocus rates BOM:539428 with a GF Score™ of 72/100 and a GF Value™ of ₹20.94 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 663 Healthcare Providers & Services companies, Tejnaksh Healthcare ranks better than 88.69% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Tejnaksh Healthcare EBITDA Margin % Related Terms
Tejnaksh Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Tejnaksh Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539428 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Tejnaksh Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tejnaksh Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tejnaksh Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Tejnaksh Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tejnaksh Healthcare (BOM:539428) has a EBITDA Margin % of 27.92% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tejnaksh Healthcare and its competitors. This is 17% below median its historical median of 33.79. Over the past decade, Tejnaksh Healthcare's EBITDA Margin % has ranged from 26.50 to 48.30. According to the industry distribution chart, Tejnaksh Healthcare ranks #75 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 11.3%.
Is Tejnaksh Healthcare's EBITDA Margin % too high?
Tejnaksh Healthcare's current EBITDA Margin % of 27.92% is 17% below median its 10-year median of 33.79. Over the past 10 years, this metric has ranged from a low of 26.50 to a high of 48.30. The Healthcare Providers & Services industry median EBITDA Margin % is 10.19. Tejnaksh Healthcare's value of 27.92% is 174% above this industry median. Based on the distribution chart, Tejnaksh Healthcare ranks #75 out of 663 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Tejnaksh Healthcare has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tejnaksh Healthcare's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tejnaksh Healthcare ranks #75 out of 663 companies for EBITDA Margin %. This places Tejnaksh Healthcare in the top 11% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.19. Tejnaksh Healthcare's value of 27.92% is 174% above this benchmark. Historically, Tejnaksh Healthcare's own EBITDA Margin % has ranged from 26.50 to 48.30 over the past decade. While the company's 10-year median is 33.79 vs. the industry median of 10.19, Tejnaksh Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.19, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tejnaksh Healthcare's current EBITDA Margin % of 27.92% is 174% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tejnaksh Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tejnaksh Healthcare's current EBITDA Margin % is 27.92%, which is 17% below median its own 10-year median of 33.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tejnaksh Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Tejnaksh Healthcare (BOM:539428) is currently considered Possible Value Trap. The stock's GF Value™ is ₹20.94, compared to a current price of ₹13.72 — trading 34.5% below its estimated fair value. The current EBITDA Margin % is 27.92%, which is 17% below median its 10-year median of 33.79 and 174% above the Healthcare Providers & Services industry median of 10.19. Tejnaksh Healthcare's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Tejnaksh Healthcare (BOM:539428), the current EBITDA Margin % is 27.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tejnaksh Healthcare (BOM:539428) Overvalued in 2026?
Based on GuruFocus' analysis, Tejnaksh Healthcare stock appears to be undervalued.
The current stock price of ₹13.72 is trading 34.5% below its estimated GF Value™ of ₹20.94.
GuruFocus considers Tejnaksh Healthcare to be Possible Value Trap.
Key valuation signals for BOM:539428:
EBITDA Margin %: 27.92% (17% below median its 10-year median of 33.79)
GF Value™: ₹20.94 vs. price of ₹13.72 (34.5% below fair value)
Industry Position: 174% above the Healthcare Providers & Services median (#75 of 663)
No single metric tells the full story. See the BOM:539428 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tejnaksh Healthcare Ltd is engaged in the provision of hospital and healthcare services. Geographically, it operates only in India. The company has a single operating segment, namely health care services. The company domains include Urology Hospitals; Nephrology Hospitals; Dental Clinics; Healthcare Equipment, Research and Development and others. It generates maximum revenue from fees charged under contract for inpatient and outpatient hospital services and also includes sale of medical and non-medical items. Hospital services include charges for accommodation, medical professional services, pathology and pharmaceutical goods used in treatments given to patient.
72GF Score
Get the complete analysis for BOM:539428
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539428 has been successfully added to your 
